As a short-chain bioregulatory peptide, Epithalon is widely researched for its potential to delay aging, extend lifespan, and modulate tumor development
New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity
You rarely need all of it, and you cannot tell which component is doing anything
Obesity Continues to Tick Down
Ongoing trials aim to quantify these benefits and establish dosing protocols that maximize effectiveness while minimizing risks
When used in conjunction with diet and exercise, it can cause significant weight loss, and possibly reduce risk of cancer, diabetes and heart disease in people who are overweight